| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | Pilocarpine Hydrochloride Tablets, USP | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 1997 | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | HYDROXYZINE PAMOATE CAPSULES USP | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TussiCaps ® (Hydrocodone Polistirex and Chlorpheniramine Polistirex) Extended-Release Capsules CIII Rx only | 1 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. Toviaz ® (fesoterodine fumarate) For oral administration Initial U.S. Approval: 2008 | 3 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | These highlights do not include all the information needed to use VIMPAT ® safely and effectively. See full prescribing information for VIMPAT. VIMPAT ® (lacosamide) Tablet, Film Coated for Oral use, CV VIMPAT ® (lacosamide) Injection for Intravenous use, CV VIMPAT ® (lacosamide) Oral Solution, CV Initial U.S. Approval: 2008 | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | Ropinirole Hydrochloride Tablets 0.25 mg, 1 mg and 5 mg Rx only | 1 | |
| Indigotindisulfonate Sodium | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3618 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | REQUIP (ROPINIROLE) TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | SERTRALINE HYDROCHLORIDE TABLET, FILM COATED [INTERNATIONAL LABS, INC.] | 26 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | VIMPAT (LACOSAMIDE) TABLET, FILM COATED VIMPAT (LACOSAMIDE) KIT VIMPAT (LACOSAMIDE) INJECTION VIMPAT (LACOSAMIDE) SOLUTION [UCB, INC.] | 26 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) CAPSULE [TEVA PHARMACEUTICALS USA INC] | 19 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 19 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 17 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | JANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.] | 16 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | KEPPRA (LEVETIRACETAM) TABLET, FILM COATED KEPPRA (LEVETIRACETAM) SOLUTION [UCB, INC.] | 16 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] | 15 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 15 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | MYCOPHENOLATE MOFETIL CAPSULE MYCOPHENOLATE MOFETIL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 15 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ACYCLOVIR CAPSULE ACYCLOVIR TABLET [TEVA PHARMACEUTICALS USA INC] | 14 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 14 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | AMERGE (NARATRIPTAN HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | 13 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FINASTERIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 13 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FLUOXETINE CAPSULE [TEVA PHARMACEUTICALS USA INC] | 13 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FAMOTIDINE TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 12 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLARITHROMYCIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FAMOTIDINE TABLET, FILM COATED [IVAX PHARMACEUTICALS, INC.] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | MINOCYCLINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | PAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | PILOCARPINE HYDROCHLORIDE TABLET, FILM COATED [LANNETT COMPANY, INC.] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | RIBAVIRIN CAPSULE [TEVA PHARMACEUTICALS USA INC] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TOPIRAMATE TABLET [TEVA PHARMACEUTICALS USA INC] | 11 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | RAMIPRIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 10 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 9 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | GLIMEPIRIDE TABLET [TEVA PHARMACEUTICALS USA INC] | 9 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | HYDROXYZINE PAMOATE CAPSULE [BARR LABORATORIES INC.] | 9 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | LEVETIRACETAM TABLET, FILM COATED LEVETIRACETAM SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 9 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | LOTRONEX (ALOSETRON HYDROCHLORIDE) TABLET [PROMETHEUS LABORATORIES INC.] | 9 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | REQUIP (ROPINIROLE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | 9 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | SOTALOL HYDROCHLORIDE TABLET [TEVA PHARMACEUTICALS USA INC] | 9 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLOPIDOGREL TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DEXTROAMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [BARR LABORATORIES INC.] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DIDANOSINE CAPSULE, DELAYED RELEASE PELLETS [BARR LABORATORIES INC.] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [WATSON LABORATORIES, INC.] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | OXYMORPHONE HYDROCHLORIDE TABLET [TEVA PHARMACEUTICALS USA INC] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TRANDOLAPRIL TABLET [TEVA PHARMACEUTICALS USA INC] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES] | 7 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FAMOTIDINE TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC] | 7 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE GALANTAMINE TABLET, FILM COATED [BARR LABORATORIES INC.] | 7 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | OLANZAPINE AND FLUOXETINE CAPSULE [TEVA PHARMACEUTICALS USA INC] | 7 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | VALACYCLOVIR TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 7 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | APRI (DESOGESTREL AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CEFDINIR CAPSULE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLOPIDOGREL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DICLOFENAC POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | METHYLPHENIDATE HYDROCHLORIDE (CD) (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | RADIOGARDASE (PRUSSIAN BLUE INSOLUBLE CAPSULES) CAPSULE [HEYL CHEM.-PHARM. FABRIK GMBH & CO. KG] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | REQUIP (ROPINIROLE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.] | 6 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DIFLUNISAL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | HYDROXYZINE PAMOATE CAPSULE [PREFERRED PHARMACEUTICALS, INC.] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LANSOPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN KIT [TEVA PHARMACEUTICALS USA INC] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | MYCOPHENOLATE MOFETIL CAPSULE MYCOPHENOLATE MOFETIL TABLET, COATED [APOTEX CORP] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | NITROFURANTOIN MACROCRYSTALS CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | OLANZAPINE TABLET, FILM COATED OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | SINEMET (CARBIDOPA AND LEVODOPA) TABLET [MERCK SHARP & DOHME CORP.] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | SINEMET CR (CARBIDOPA AND LEVODOPA) TABLET, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | SURMONTIL (TRIMIPRAMINE MALEATE) CAPSULE [TEVA WOMEN'S HEALTH, INC.] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TEMOZOLOMIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] | 5 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.] | 5 | |
| indigotindisulfonate sodium | INACTIVE INGREDIENT | D3741U8K7L | ALOSETRON HYDROCHLORIDE TABLET [ACTAVIS PHARMA, INC.] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLOPIDOGREL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | HYDROXYZINE PAMOATE CAPSULE [MYLAN INSTITUTIONAL INC.] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | KARIVA (DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LETROZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | MYCOPHENOLATE MOFETIL CAPSULE MYCOPHENOLATE MOFETIL TABLET, COATED [AMERICAN HEALTH PACKAGING] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | NITROFURANTOIN MACROCRYSTALS CAPSULE [TEVA PHARMACEUTICALS USA INC] | 4 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | AMLODIPINE, VALSARTAN, AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLOPIDOGREL TABLET, FILM COATED [ST MARYS MEDICAL PARK PHARMACY] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LAMOTRIGINE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [GOLDEN STATE MEDICAL SUPPLY, INC.] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [U.S. PHARMACEUTICALS] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TREXALL (METHOTREXATE) TABLET, FILM COATED [TEVA WOMEN'S HEALTH, INC.] | 3 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | AMLODIPINE AND VALSARTAN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ANAGRELIDE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLARITHROMYCIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DAKLINZA (DACLATASVIR) TABLET [E.R. SQUIBB & SONS, L.L.C.] | 2 | |
| Indigotindisulfonate Sodium | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| INDIGOTINDISULFONATE SODIUM | ACTIVE INGREDIENT | D3741U8K7L | INDIGO CARMINE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | KEPPRA (LEVETIRACETAM) TABLET, FILM COATED [REMEDYREPACK INC. ] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | LOSARTAN POTASSIUM TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | NITROFURANTOIN MACROCRYSTALS CAPSULE [UNIT DOSE SERVICES] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | QUARTETTE (LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL) KIT [TEVA WOMEN'S HEALTH, INC.] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | RAMIPRIL CAPSULE [UNIT DOSE SERVICES] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | WARFARIN SODIUM TABLET [CLINICAL SOLUTIONS WHOLESALE, LLC] | 2 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ACYCLOVIR CAPSULE [PROFICIENT RX LP] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | AMOXICILLIN CAPSULE [DIRECT RX] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | BITE BEAUTY SPF 15 SHEER BALM (OCTINOXATE OXYBENZONE) OINTMENT [SUSANNE LANG FRAGRANCE INC.] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | DACLATASVIR TABLET [BRISTOL-MYERS SQUIBB COMPANY] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ENTECAVIR TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | ESZOPICLONE (ESZOPICLONE) TABLET, FILM COATED [AVKARE, INC.] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FAMOTIDINE TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) TABLET, FILM COATED [PROFICIENT RX LP] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | GENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.] | 1 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | HERBAL UTAPLAS.TN (MENTHOL, METHYL SALICYLATE) PATCH [ALBERT MAX, INC.] | 1 | |
| Indigotindisulfonate Sodium | ACTIVE INGREDIENT | D3741U8K7L | INDIGO CARMINE (INDIGOTINDISULFONATE SODIUM) INJECTION, SOLUTION [AKORN, INC.] | 1 | |
| Indigotindisulfonate Sodium | ACTIVE INGREDIENT | D3741U8K7L | INDIGO CARMINE (INDIGOTINDISULFONATE SODIUM) INJECTION, SOLUTION [AKORN, INC.] | 1 | |